155 related articles for article (PubMed ID: 32353633)
1. ADA2 deficiency complicated by EBV-driven lymphoproliferative disease.
Staples E; Simeoni I; Stephens JC; Allen HL; ; Wright P; Davies EG; Javid B; Gkrania-Klotsas E; Gattens M; Firth H; Shamardina O; Deevi SVV; Prapa M; Uttenthal B; Kumararatne D; Thaventhiran JED
Clin Immunol; 2020 Jun; 215():108443. PubMed ID: 32353633
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
Schnappauf O; Zhou Q; Moura NS; Ombrello AK; Michael DG; Deuitch N; Barron K; Stone DL; Hoffmann P; Hershfield M; Applegate C; Bjornsson HT; Beck DB; Witmer PD; Sobreira N; Wohler E; Chiorini JA; Center TAG; Dalgard CL; Center NIS; Kastner DL; Aksentijevich I
J Clin Immunol; 2020 Aug; 40(6):917-926. PubMed ID: 32638197
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency.
Schepp J; Bulashevska A; Mannhardt-Laakmann W; Cao H; Yang F; Seidl M; Kelly S; Hershfield M; Grimbacher B
J Clin Immunol; 2016 Apr; 36(3):179-86. PubMed ID: 26922074
[TBL] [Abstract][Full Text] [Related]
4. Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection.
Gardner LS; Vaughan L; Avery DT; Meyts I; Ma CS; Tangye SG; Varikatt W; Lin MW
J Clin Immunol; 2024 May; 44(5):118. PubMed ID: 38758417
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.
Van Montfrans JM; Hartman EA; Braun KP; Hennekam EA; Hak EA; Nederkoorn PJ; Westendorp WF; Bredius RG; Kollen WJ; Schölvinck EH; Legger GE; Meyts I; Liston A; Lichtenbelt KD; Giltay JC; Van Haaften G; De Vries Simons GM; Leavis H; Sanders CJ; Bierings MB; Nierkens S; Van Gijn ME
Rheumatology (Oxford); 2016 May; 55(5):902-10. PubMed ID: 26867732
[TBL] [Abstract][Full Text] [Related]
7. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation.
Barzaghi F; Minniti F; Mauro M; Bortoli M; Balter R; Bonetti E; Zaccaron A; Vitale V; Omrani M; Zoccolillo M; Brigida I; Cicalese MP; Degano M; Hershfield MS; Aiuti A; Bondarenko AV; Chinello M; Cesaro S
Front Immunol; 2018; 9():2767. PubMed ID: 30692987
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis.
Alsultan A; Basher E; Alqanatish J; Mohammed R; Alfadhel M
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29271561
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Interindividual variability and possible role of heterozygous variants in a family with deficiency of adenosine deaminase 2: are all heterozygous born equals?
Pulvirenti F; Cinicola BL; Ferrari S; Guadagnolo D; Sculco E; Capponi M; Loffredo L; Sciannamea M; Insalaco A; Quinti I; De Benedetti F; Zicari AM
Front Immunol; 2023; 14():1156689. PubMed ID: 37207212
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated leiomyomatosis and posttransplant lymphoproliferative disorder in a child with severe combined immunodeficiency: case report and review of the literature.
Monforte-Muñoz H; Kapoor N; Saavedra JA
Pediatr Dev Pathol; 2003; 6(5):449-57. PubMed ID: 14708738
[TBL] [Abstract][Full Text] [Related]
11. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).
Brooks JP; Rice AJ; Ji W; Lanahan SM; Konstantino M; Dara J; Hershfield MS; Cruickshank A; Dokmeci E; Lakhani S; Lucas CL
J Clin Immunol; 2021 Apr; 41(3):680-683. PubMed ID: 33394316
[No Abstract] [Full Text] [Related]
12. Successful treatment of lymphoproliferative disease complicating primary immunodeficiency/immunodysregulatory disorders with reduced-intensity allogeneic stem-cell transplantation.
Cohen JM; Sebire NJ; Harvey J; Gaspar HB; Cathy C; Jones A; Rao K; Cubitt D; Amrolia PJ; Davies EG; Veys P
Blood; 2007 Sep; 110(6):2209-14. PubMed ID: 17502458
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
15. Early-onset stroke and vasculopathy associated with mutations in ADA2.
Zhou Q; Yang D; Ombrello AK; Zavialov AV; Toro C; Zavialov AV; Stone DL; Chae JJ; Rosenzweig SD; Bishop K; Barron KS; Kuehn HS; Hoffmann P; Negro A; Tsai WL; Cowen EW; Pei W; Milner JD; Silvin C; Heller T; Chin DT; Patronas NJ; Barber JS; Lee CC; Wood GM; Ling A; Kelly SJ; Kleiner DE; Mullikin JC; Ganson NJ; Kong HH; Hambleton S; Candotti F; Quezado MM; Calvo KR; Alao H; Barham BK; Jones A; Meschia JF; Worrall BB; Kasner SE; Rich SS; Goldbach-Mansky R; Abinun M; Chalom E; Gotte AC; Punaro M; Pascual V; Verbsky JW; Torgerson TR; Singer NG; Gershon TR; Ozen S; Karadag O; Fleisher TA; Remmers EF; Burgess SM; Moir SL; Gadina M; Sood R; Hershfield MS; Boehm M; Kastner DL; Aksentijevich I
N Engl J Med; 2014 Mar; 370(10):911-20. PubMed ID: 24552284
[TBL] [Abstract][Full Text] [Related]
16. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27.
Salzer E; Daschkey S; Choo S; Gombert M; Santos-Valente E; Ginzel S; Schwendinger M; Haas OA; Fritsch G; Pickl WF; Förster-Waldl E; Borkhardt A; Boztug K; Bienemann K; Seidel MG
Haematologica; 2013 Mar; 98(3):473-8. PubMed ID: 22801960
[TBL] [Abstract][Full Text] [Related]
17. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
18. Enzyme activity in dried blood spot as a diagnostic tool for adenosine deaminase 2 deficiency.
Ito M; Nihira H; Izawa K; Yasumi T; Nishikomori R; Iwaki-Egawa S
Anal Biochem; 2021 Sep; 628():114292. PubMed ID: 34171384
[TBL] [Abstract][Full Text] [Related]
19. IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.
Fellmann F; Angelini F; Wassenberg J; Perreau M; Arenas Ramirez N; Simon G; Boyman O; Demaria O; Christen-Zaech S; Hohl D; Belfiore M; von Scheven-Gete A; Gilliet M; Bochud PY; Perrin Y; Beck Popovic M; Bart PA; Beckmann JS; Martinet D; Hofer M
J Allergy Clin Immunol; 2016 Apr; 137(4):1189-1196.e2. PubMed ID: 26607704
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
